U.S. market Closed. Opens in 1 day 4 hours 57 minutes

TCRR | TCR2 Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A
Operating Expenses123.08M99.74M68.70M51.38M26.45M13.18M9.93M
Selling, General & Admin24.44M22.50M16.72M13.89M6.78M3.61M2.26M
Research & Development98.64M77.24M51.98M37.49M19.67M9.57M7.67M
Other Operating Expenses30.42MN/AN/AN/AN/AN/AN/A
Operating Income-153.50M-99.74M-68.70M-51.38M-26.45M-13.18M-9.93M
Other Expenses / Income1.94M224.00K1.74M3.88M2.20M110.00K15.00K
Before Tax Income-151.56M-99.52M-66.96M-47.50M-24.25M-13.07M-9.91M
Income Tax Expenses261.00K289.00K161.00K102.00K2.20M110.00K15.00K
Net Income-151.82M-99.81M-67.12M-47.60M-24.25M-13.07M-9.91M
Interest Expenses58.90MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding38.63M37.94M27.99M21.10M23.19M5.13M5.13M
Diluted Shares Outstanding38.63M37.94M27.99M21.10M23.19M5.13M5.13M
EBITDA-89.62M-96.92M-67.11M-50.52M-23.83M-12.77M-9.70M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-92.67M-99.52M-66.96M-47.50M-22.05M-12.96M-9.90M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙